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Mesenchymal stem cells hold great promise for regenerative medicine as they can be easily isolated from different sources such as
adipose tissue, bone marrow, and umbilical cord blood. Spontaneously arising pluripotent stem cells can be obtained in culture
from murine spermatogonial stem cells (SSCs), while the pluripotency of the human counterpart remains a matter of debate.
Recent gene expression profiling studies have demonstrated that embryonic stem cell- (ESC-) like cells obtained from the
human testis are indeed closer to mesenchymal stem cells (MSCs) than to pluripotent stem cells. Here, we confirm that colonies
derived from human testicular cultures, with our isolation protocol, are of mesenchymal origin and do not arise from
spermatogonial stem cells (SSCs). The testis, thus, provides an important and accessible source of MSCs (tMSCs) that can be
potentially used for nephrotoxicity testing in vitro. We further demonstrate, for the first time, that tMSCs are able to secrete
microvesicles that could possibly be applied to the treatment of various chronic diseases, such as those affecting the kidney.
1. Introduction
Mesenchymal stem cells (MSCs) are multipotent stem cells
first postulated by Owen et al. to be derived from bone
marrow [1]. Since then, this stromal cell type has been found
in a myriad of different tissues [2–4]. As MSCs are able to
home to sites of inflammation and differentiate into various
cell types and are immunomodulatory, they are ideal
candidates for clinical applications. Unlike multipotent stem
cells, SSCs are unipotent stem cells that reside on the basal
membrane of the testis and can give rise only to spermatozoa.
SSCs are defined by their ability to balance between self-
renewal and differentiation, a feature which is supported by
Sertoli and stromal cells that represent the main components
of the SSC niche [5]. The study of SSCs has always been
challenging as they are very limited in number [6, 7], and
specific markers have not yet been identified [8].
Intriguingly, murine SSCs, under specific culture condi-
tions, are able to spontaneously convert into pluripotent
embryonic-like stem cells, known as germline cell-derived
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pluripotent stem cells (GPSCs) [9–12]. Recently, a number of
groups have claimed that pluripotent stem cells can be
derived from unipotent human SSCs [13, 14]. Nevertheless,
these findings have been subsequently challenged [15],
demonstrating that these “embryonic-like colonies” have
an expression profile more similar to that of fibroblasts
than to that of embryonic stem cells (ESCs) [16] and
are, in fact, of mesenchymal origin [17, 18].
Here, we confirm that a mesenchymal population can be
easily established from small human biopsies without
employing any particular separation protocol. Interestingly,
we demonstrate that these testicular MSCs (tMSCs) can be
established from very small testis biopsies making them an
attractive and novel source of MSC for cell therapy. Further-
more, we evaluate the microvesicle profile of these tMSCs
derived from the human testis, which was never shown
before. The therapeutic potential of extracellular vesicles
is very broad, with applications including as a drug deliv-
ery route and as biomarkers for diagnosis [19, 20]. Extra-
cellular vesicles extracted from stem cells may be used for
treatment of many diseases including those affecting the
kidney [21–23].
2. Materials and Methods
2.1. Culture Conditions and Isolation Protocol. tMSC colonies
were derived from primary testicular cultures, starting with
1× 106 to 1× 107 cells and are based on previously published
protocols [24, 25], from frozen-thawed testis material of
TESE (testicular sperm extraction) pellets of 10 individuals
that underwent IVF (in vitro fertilization). The protocol
was approved by the LIVET Srl local Ethical Committee
(approval date 14 March 2015). After obtaining the written
informed consent, the testis material was donated for
research. Testicular cells were isolated with a cocktail of
enzymes, trypsin (Sigma), collagenase type I (Worthington),
and hyaluronidase (Sigma), in MEM1x (Invitrogen) con-
taining DNase (Sigma) and cultured in supplemented
StemPro-34 (Invitrogen) medium as previously described
for mouse testicular cells [26], with the omission of feeder
cells. After their initial appearance, colonies morphologically
resembling ESC colonies were picked and subcultured as
described previously [27] with some modifications. Briefly,
individual colonies were subcultured in ESC medium
composed of DMEM-KO medium (Invitrogen), 20% ES
qualified fetal calf serum (FCS, Gibco), 0.01mM nonessential
amino acid (NEAA, Gibco), 100U/ml penicillin (Gibco),
100μg/ml streptomycin (Gibco), 0.05mM β-mercaptoetha-
nol (Sigma), a cocktail of insulin, transferrin, and sodium
selenite (10μg/ml, 5.5μg/ml, and 5ng/ml, resp.; ITS 100X,
Sigma), and 25ng/ml bFGF (basic fibroblast growth factor,
Voden). Testicular somatic cells (TSCs) were isolated using
the same protocol and maintained in MEM1x (Invitrogen)
with 10% FCS.
2.2. Culture of IMCD3. IMCD3 (inner medullary collecting
duct cells) were maintained in DMEM-F12 (Invitrogen)
added with calf serum (Gibco), 100U/ml penicillin (Gibco),
and 100μg/ml streptomycin (Gibco).
2.3. Analysis of mRNA Expression. Total RNA was extracted
from tMSCs at passage 6, according to the manufacturer’s
instruction (TRI Reagent®, Ambion). cDNA was synthesized
starting from 500ng of RNA as previously described [28].
Quantitative real-time PCR was performed using the follow-
ing sets of primers: VASA (forward: 5′-CGCCAAACCCT
TATGTTCAG-3′ and reverse: 5′-AAAAACTCTGCAGC
CAACCTT-3′), VIMENTIN (forward: 5′-TACAGGAAG
CTGCTGGAAGG-3′ and reverse: 5′-ACCAGAGGGAG
TGAATCCAG-3′), CD90 (forward: 5′-AGGACGAGGGC
ACCTACAC-3′ and reverse: 5′-GCCCTCACTTGACCAG
TT-3′), NANOG (forward: 5′-AGATGCCTCACACGGA
GAC-3′ and reverse: 5′-TTTGCGACACTCTTCTCTGC-3′),
SOX2 (forward: 5′-TGCTGCCTCTTTAAGACTA-3′ and
reverse: 5′-CCTGGGGCTCAAACTTCTCT-3′), and OCT4
(forward: 5′-CTTCGCAAGCCCTCATTTC-3′ and reverse:
5′-GAGAAGGCGAAATCCGAAG-3′).
2.4. Immunofluorescence Staining. tMSCs were fixed with 4%
paraformaldehyde for 10 minutes, and the primary antibody
was diluted in 1% bovine serum albumin (BSA, Sigma)
and incubated for 1 h at room temperature. The goat poly-
clonal anti-vimentin (Santa Cruz) antibody was used.
Nuclei were counterstained with DAPI (4,6 diamidino-2-
phenylindole, Sigma).
2.5. Flow Cytometry Analysis. Flow cytometry was performed
using a FACSCalibur Cytometer (BD Biosciences); a
phenotyping kit (MSC phenotyping kit, Miltenyi) was used
to characterize the tMSCs. The following antibodies were
used: anti-CD34PerCP, anti-CD45PerCP, anti-CD20PerCP,
anti-CD14PerCP, anti-CD73APC, anti-CD9FITC, and anti-
CD105PE (BD Pharmingen). Matched isotype controls were
applied to determine background fluorescence levels.
2.6. Adipogenic Differentiation and Oil Red Staining. tMSCs
were plated at a density of 3× 105 in a 6-well culture dish
and incubated O/N in a humidified incubator. Adipogenic
induction medium was prepared in DMEM-low glucose
(Invitrogen) with the addition of 10% fetal bovine serum
(FBS), 10mM dexamethasone (Sigma), 10mg/mL insulin
(Sigma), 100U/ml penicillin (Gibco), and 100μg/ml strepto-
mycin (Gibco). Adipogenic maintenance medium was pre-
pared as the induction medium with the exception of
dexamethasone. The medium was added following the differ-
entiation schedule: 4 days in the induction medium and 2
days in the maintenance medium (repeated 3 times).
For the red oil staining, cells were fixed for 10′ in 4%
paraformaldehyde (PFA) and then incubated for 10′ in 60%
isopropanol. The staining for the lipid droplets was
accomplished through the incubation of cells with oil red O
solution (Sigma) for 5′, and then the cells were washed with
phosphate-buffered saline (PBS) and mounted. Nuclei were
counterstained with hematoxylin (Bioptica).
2.7. Osteogenic Differentiation and Alizarin Red Staining.
tMSCs were plated at a density of 1× 105 in a 6-well culture
dish and incubated O/N in a humidified incubator. Cells
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were treated for 3 weeks with a commercial medium for
osteogenic differentiation (Euroclone). For alizarin red S
staining, cells were fixed for 10′ in 4% PFA and stained with
the alizarin red solution (Sigma) for 30″ to 5′, while observ-
ing the reaction microscopically. Cells were dehydrated in
acetone and mounted. Nuclei were counterstained with
hematoxylin (Bioptica).
2.8. Alkaline Phosphatase Staining. For the alkaline
phosphatase assay, cells at passage 6 were seeded onto a
chamber slide (Thermo Scientific) and allowed to reach
80% confluence. They were then fixed with 4% PFA for 2′
and stained with a commercial kit, according to the manufac-
turer’s instruction (Millipore).
2.9. Microvesicle (MV) Isolation from tMSCs and TSCs. MVs
were isolated according to previously published protocols
[21]. Briefly, MVs were obtained from supernatants of tMSCs
at early passages (p6) and from testicular somatic cells as a
control. tMSCs were cultured in DMEM-KO (Invitrogen),
and testicular somatic cells in MEM1x (Invitrogen)
both deprived of FCS for 24h. After centrifugation at
3000RPM for 10′ to remove debris, cell-free supernatants
were centrifuged at 100,000g (Beckman Coulter Optima
L-100K ultracentrifuge) for 2 h at 4°C. MV concentration
was determined by protein quantification (Bradford assay,
Bio-Rad).
2.10. Labelling of MVs Derived from tMSCs. 50μg/ml of MVs
was labelled with PKH67 dye (Sigma) according to the
manufacturer’s protocol. The MVs were then incubated on
IMCD3 for 4 h, 12 h, and 24h at 37°C. Following incubation,
the cells were fixed, counterstained with DAPI, and analyzed
by fluorescence microscopy.
2.11. Statistical Analysis. Values are reported as the
mean± standard error of mean. Statistical analysis was
performed by using two-tailed Student’s t-tests (∗P < 0 05,
∗∗P < 0 01, and ∗∗∗P < 0 001) for the graphs comparing
only two variables. For the analysis of more than two
categories, the statistical significance was calculated with
one-way ANOVA and Bonferroni posttest (∗P < 0 05,
∗∗P < 0 01, and ∗∗∗P < 0 001). All the analyses were per-
formed with PRISM5 (GraphPad Software Inc., La Jolla
CA, USA).
(a) (b)
(c) (d)
Figure 1: Appearance of tMSC colonies. The day after cell purification from testis biopsies, a mixed population of cells was present in the
culture (a). Floating clusters started to appear between 1 week and 3 weeks postseparation (b, c). Once isolated and cultured on plastic,
these colonies start to expand and proliferate (d). Original magnification: ×200.
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3. Results
3.1. Mesenchymal Stem Cells from Testis Biopsies. Due to a
lack of specific markers for SSCs [8], we chose not to sort
our mixed population, composed of somatic cells, Sertoli
cells, and SSCs (Sup. Figure S1A, B, and C), isolated from
testicular biopsies. One week postisolation, some cells
formed aggregated floating colonies (Figure 1(a)) and
became granulated with time (Figures 1(b) and 1(c)). Two
days after picking, colonies attached to the plates and started
to proliferate (Figure 1(d)), but despite their resemblance to
ESC colonies, further analysis revealed the nongermline
origin of these cells (referred to as testicular mesenchymal
stem cells (tMSCs) from now on) (Figure 2). We successfully
isolated 27 colonies from up to 10 different biopsies, and we
were able to maintain them in culture for at least 20 passages
with comparable proliferation rates. All colonies analyzed
gave equivalent results and showed the same mesenchymal
characteristics. RNA was extracted at different passages.
The expression of VASA was not detected in any colony
(Figure 2(b)). VASA is a specific protein expressed by
mammalian germ cells [29], and it is essential for germ cell
development [30]. Furthermore, cells derived from these
colonies expressed high levels of vimentin, a typical mesen-
chymal marker, at both mRNA (Figure 2(a)) and protein
level (Figure 2(c)). When we analyzed the expression of
pluripotent markers in numerous tMSC colonies, none were
found to be positive for any of the classical pluripotent
markers (Sup. Figure S2A, B, and C). Moreover, they were
unable to give rise to any of the three embryonic germ layers
(data not show). The ability to grow on plastic and differen-
tiate toward three mesodermal lineages (adipo-, osteo-, and
chondrogenic) and the relevant presence and absence of
specific antigens are the defining criteria of MSCs [31]. These
colony-derived tMSCs were capable of growing on plastic
(Figure 3(a)) and were positive for CD105, CD73, and
CD90 (Figure 3(g)) and negative for CD14 and CD34
(Figure 3(h)). Finally, under appropriate conditions, tMSC
differentiated toward mesodermal lineages. In the case of
osteogenic differentiation, calcium deposition was observed
(Figure 3(e)), while lipid accumulation (Figure 3(f)) was
observed in the case of adipogenic differentiation of tMSCs.
Intriguingly, some of the tMSC colonies showed positive
staining for alkaline phosphatase (AP) (Figure 3(c)). Once
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Figure 2: Mesenchymal phenotype of isolated tMSCs. Cells expanded from tMSC colony strongly express vimentin both at mRNA level
(a) and at protein level (c). Moreover, they do not express VASA (b), a marker of cells originating from the germ lineage. Original
magnification: (c) ×630.
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isolated and cultured, these colonies, regardless of their initial
positive staining for AP, gave rise to a mixed population of
cells, in which about 50% of tMSCs were positive for AP
(Figures 3(b) and 3(d)), reflecting the heterogeneous
nature of other types of MSCs [32]. AP is demonstrated
to be identical to the mesenchymal stem cell antigen
MSCA-1 [33], and it can be used as a selective marker
for MSC isolation [34]. Taken together, this data confirms
the mesenchymal nature of these colonies and demonstrates
for the first time the expression of AP in MSCs isolated from
the human testis.
3.2. Characterization of MVs Derived from tMSCs.MVs were
isolated from tMSCs following ultracentrifugation of the
serum-starved culture supernatant. tMSC-derived microvesi-
cles were labelled with PKH26 dye. IMCD3 (inner medullary
collecting duct cells) were treated with the MV suspension
for 4 h, 12 h, and 24 h. Uptake of MVs by the renal cells
was evident at 4 h postincubation and continued in a
time-dependent manner reaching the maximum uptake
24 h postincubation (Figure 4(a)). Intriguingly, we found
that the testicular somatic cells used as a control were able
to secrete MVs incorporated by the IMCD3, though to a
lesser extent (data not shown). Real-time PCR analysis
of these MVs was performed in order to evaluate their
mRNA composition and verify their mesenchymal origin.
We demonstrated that tMSC-MVs of mesenchymal origin
express higher level of both vimentin and CD90 mRNA than
MVs isolated from testicular somatic cells (Figure 4(b)).
Taken together, this data demonstrates for the first time that
tMSCs are able to secrete MVs that are easily taken up by
renal cells.
4. Discussion
Mesenchymal stem cells can be obtained from a number of
different tissues, including bone marrow [4], umbilical cord
[2], and adipose tissue [3]. It has been previously suggested
that testicular tissue contains a mesenchymal population
[35] of cells, and a study from 2014 identified these mesen-
chymal progenitors as the source of the ESC-like colonies
isolated from the human testis [17]. In the present study,
we confirmed independently that the “ESC-like” colonies
arising from human testicular culture are indeed of
mesenchymal origin and do not possess any pluripotent
characteristics. Furthermore, we demonstrated the feasibility
of isolating tMSC-derived MVs, highlighting the utility of
this novel source of mesenchymal stem cells as an avenue
to derive MVs for regenerative medicine applications.
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Figure 3: Characterization of the mesenchymal phenotype of tMSCs. (a–d) A representative picture of a tMSC colony (a) positive for AP
staining and the correspondent colony in brightfield (c). Once picked and expanded, the colonies gave rise to a heterogeneous population
expressing alkaline phosphatase (b–d). (e–f) Representative pictures of alizarin red staining (e) and oil red staining (f) of tMSCs,
indicating osteogenic and adipogenic differentiation. Negative staining is represented on the left side, and positive staining on the right
side. Original magnification: (a–c) ×100, (d) ×200, and (e, f) ×100. (g, h) A flow cytometry analysis of one of the tMSC colonies (colony
#27). The analysis demonstrates that the cells are positive for CD73, CD105, and CD90 (g). As expected, the cells are negative for CD14,
CD34, and HLA-DR (h). This analysis is representative of three independent experiments performed on various colonies.
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Figure 4: GFP+ MVs derived from tMSCs are incorporated by IMCD3. (a) Representative pictures of IMDC3 incubated with GFP-labelled
MVs at 4, 12, and 24 hours and the control (CTRL) cells incubated only with the labelling reagent. The MVs are progressively fused with the
cells as demonstrated by the increased amount of fluorescence. Original magnification: ×400. (b) Finally, real-time analysis shows that MVs
derived from tMSCs are positively enriched in vimentin and CD90 when compared to the MVs obtained from testicular somatic cells isolated
from the same biopsy (TSC-MVs) (N = 3, ∗P < 0 05).
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Different lines of tMSCs were established from up to 10
testis biopsies, all with consistent features. The isolated
colonies started to appear after differential passaging around
7–14 days postisolation. Although the shape of the colonies
closely resembled that of ESC colonies, once isolated, they
became granulated, giving rise to a population of “spindle”-
like cells able to grow on plastic as a single layer. This popu-
lation of cells was positive for the expression of the mesen-
chymal marker vimentin at both RNA and protein levels. It
is interesting to note that none of the populations arising
from the various colonies showed any indication of pluripo-
tency. When cultured in suspension, these tMSCs failed to
form embryoid bodies and died afterwards (data not shown).
OCT4, NANOG, and SOX2 expression was barely detectable
in all of the colonies analyzed, and no expression of VASA
was detected. Intriguingly, VASA expression was present in
the initial mixed population isolated from testis biopsies,
ruling out the possibility that the lack of VASA expression
might be due to the absence of a germline population in
the starting sample. When we evaluated the mesenchymal
features of the testis-derived colonies, we found that not
only did the cells express all the classical markers of
MSCs (CD90, CD73, and CD104) but also they differen-
tiated into cells of mesodermal origin with ease. Interest-
ingly, we found the tMSCs to be positive for AP, another
MSC marker, which was never shown before. The
heterogeneous expression of AP among the cells is in line
with their mesenchymal origin [36]. With a small biopsy,
tMSCs are easily derived and exhibit a relatively extended
life span compared to other “classical” MSCs [36], making
these testicular mesenchymal stem cells amenable to expan-
sion for therapeutic purposes, an attractive proposition for
regenerative medicine.
A growing body of evidence has demonstrated that MSCs
act through a paracrine effect by secreting soluble factors and
microvesicles [37, 38]. MVs derived from mesenchymal stem
cells can reprogram target cells suggesting that they could be
exploited in regenerative medicine to repair damaged tissues,
and in particular, they have been demonstrated to be
efficacious in preventing acute renal injury [22, 39, 40].
MVs isolated from MSCs were successfully incorporated by
IMCD3, in which the GFP staining is already present 4 h
postincubation. The GFP+ signal increases over the time,
demonstrating that the incorporation of MVs is time
dependent. IMCD3 is an epithelial cell line derived from
the inner medullary collecting ducts of the murine kidney;
this observation may be important in light of a possible use
for tMSC-MVs in the repair of renal injury. Finally, the statis-
tically relevant expression of the two mesenchymal markers
vimentin and CD90 confirms that the tMSC-MVs are defin-
itively derived from a mesenchymal population.
5. Conclusions
In conclusion, we have demonstrated for the first time that
mesenchymal stem cells isolated from small testis biopsies
are positive for AP expression and are able to secrete MVs
that can be successfully taken up by renal cells. Further
analyses are required to evaluate the relevant biological
activity of these new tMSC-derived MVs, with the possibility
of exploiting their role and contribution in the repair of
various chronic and acute diseases, as well as in nephrotoxi-
city testing in vitro.
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